An ischemic area-targeting, peroxynitrite-responsive, biomimetic carbon monoxide nanogenerator for preventing myocardial ischemia-reperfusion injury
Jinyan Zhang,Liwei Liu,Zhen Dong,Xicun Lu,Wenxuan Hong,Jin Liu,Xiaoyi Zou,Jinfeng Gao,Hao Jiang,Xiaolei Sun,Kai Hu,Youjun Yang,Junbo Ge,Xiao Luo,Aijun Sun
DOI: https://doi.org/10.1016/j.bioactmat.2023.05.017
IF: 18.9
2023-06-26
Bioactive Materials
Abstract:Highlights • A biomimetic nanoplatform was constructed for precise delivery of carbon monoxide (CO) donor to ischemia reperfusion area. • M/ could realize controlled release of CO by reacting with peroxynitrite (ONOO − ). • M/ could ameliorate myocardial ischemia-reperfusion (MI/R) injury by clearing harmful ONOO − , attenuating inflammatory response, inhibiting cardiomyocyte apoptosis, and promoting mitochondrial biogenesis. Myocardial ischemia-reperfusion (MI/R) injury is common in patients who undergo revascularization therapy for myocardial infarction, often leading to cardiac dysfunction. Carbon monoxide (CO) has emerged as a therapeutic molecule due to its beneficial properties such as anti-inflammatory, anti-apoptotic, and mitochondrial biogenesis-promoting properties. However, its clinical application is limited due to uncontrolled release, potential toxicity, and poor targeting efficiency. To address these limitations, a peroxynitrite (ONOO − )-triggered CO donor (PCOD585) is utilized to generate a poly (lactic-co-glycolic acid) (PLGA)-based, biomimetic CO nanogenerator (M/) that is coated with the macrophage membrane, which could target to the ischemic area and neutralize proinflammatory cytokines. In the ischemic area, local produced ONOO − triggers the continuous release of CO from M/, which efficiently ameliorates MI/R injury by clearing harmful ONOO − , attenuating the inflammatory response, inhibiting cardiomyocyte apoptosis, and promoting mitochondrial biogenesis. This study provides a novel insight into the safe therapeutic use of CO for MI/R injury by utilizing a novel CO donor combined with biomimetic technology. The M/ nanogenerator offers targeted delivery of CO to the ischemic area, minimizing potential toxicity and enhancing therapeutic efficacy. Graphical abstract Download : Download high-res image (445KB) Download : Download full-size image Illustrations displaying the preparation process of the macrophage cell membrane-camouflaged M/ and the mechanism of M/ to treat MI/R injury. The process is divided into 3 steps: 1) macrophage membrane coating promotes accumulation of nanoparticles () in ischemic area of heart.2) M/ is internalized by nearby cells and release PCOD585, which react with ONOO − to release CO.3) CO inhibits apoptosis, decreases pro-inflammatory macrophage, and facilitates the mitochondrial biogenesis.
engineering, biomedical,materials science, biomaterials